Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARM · BSE: 507789 · Pharmaceuticals & Biotechnology · 45 announcements

Share price: ₹235.99
Market cap: ₹1,557 Cr
Revenue (annual): ₹287.2 Cr
Net profit (annual): ₹43.08 Cr
P/E (TTM): 34.2×Sector 47.4×
Promoter holding: 69.05%+1.16% QoQ
FII holding: 2.30%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Merger & Restructuring 11 Employee Stock Options 9 Financial Results 4 Earnings Call 4 Annual General Meeting 4 Management Change 3 Other Announcement 2 Dividend 2 Board Meeting Outcome 2 Results Update 1 Business Update 1 Board Meeting Date 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

20 Apr 2026 17:07 IST NSE

Board Meeting Outcome

Jagsonpal Pharmaceuticals Board Meeting Outcome

Jagsonpal Pharmaceuticals Limited has scheduled a Board Meeting on April 27, 2026, to approve audited standalone yearly financial results and recommend a final dividend. The trading window remains closed until April 29, 2026.

Read the filing ↗

20 Apr 2026 17:07 IST BSE

Board Meeting Outcome

Jagsonpal Pharmaceuticals Board Meeting Outcome

Jagsonpal Pharmaceuticals Ltd has scheduled a Board Meeting on April 27, 2026. The board will consider and approve audited financial results for the quarter and year ended March 31, 2026, and evaluate a potential dividend recommendation for the financial year.

Read the filing ↗